Mitra Biotech: Program Partner
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery.
Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation, it can be used to predict response of an indication to a specific drug (or drug combination), or to better understand MOA of a given compound.
Founded in 2010, Mitra is headquartered in Boston and maintains a significant research and laboratory presence in Bangalore, India.